Nwadozi Emmanuel, Rudnicki Martina, Haas Tara L
School of Kinesiology and Health Science, Angiogenesis Research Group and Muscle Health Research Centre, York University, Toronto, ON, Canada.
Front Cell Dev Biol. 2020 Feb 14;8:77. doi: 10.3389/fcell.2020.00077. eCollection 2020.
Pericytes are mural vascular cells found predominantly on the abluminal wall of capillaries, where they contribute to the maintenance of capillary structural integrity and vascular permeability. Generally quiescent cells in the adult, pericyte activation and proliferation occur during both physiological and pathological vascular and tissue remodeling. A considerable body of research indicates that pericytes possess attributes of a multipotent adult stem cell, as they are capable of self-renewal as well as commitment and differentiation into multiple lineages. However, pericytes also display phenotypic heterogeneity and recent studies indicate that lineage potential differs between pericyte subpopulations. While numerous microenvironmental cues and cell signaling pathways are known to regulate pericyte functions, the roles that metabolic pathways play in pericyte quiescence, self-renewal or differentiation have been given limited consideration to date. This review will summarize existing data regarding pericyte metabolism and will discuss the coupling of signal pathways to shifts in metabolic pathway preferences that ultimately regulate pericyte quiescence, self-renewal and -differentiation. The association between dysregulated metabolic processes and development of pericyte pathologies will be highlighted. Despite ongoing debate regarding pericyte classification and their functional capacity for -differentiation , pericytes are increasingly exploited as a cell therapy tool to promote tissue healing and regeneration. Ultimately, the efficacy of therapeutic approaches hinges on the capacity to effectively control/optimize the fate of the implanted pericytes. Thus, we will identify knowledge gaps that need to be addressed to more effectively harness the opportunity for therapeutic manipulation of pericytes to control pathological outcomes in tissue remodeling.
周细胞是一种血管壁细胞,主要存在于毛细血管的无腔壁上,对维持毛细血管结构完整性和血管通透性起作用。在成年人中,周细胞通常处于静止状态,在生理性和病理性血管及组织重塑过程中会发生周细胞激活和增殖。大量研究表明,周细胞具有多能成体干细胞的特性,因为它们能够自我更新,以及定向分化为多个谱系。然而,周细胞也表现出表型异质性,最近的研究表明不同周细胞亚群的谱系潜能有所不同。虽然已知许多微环境信号和细胞信号通路可调节周细胞功能,但代谢途径在周细胞静止、自我更新或分化中所起的作用,迄今为止受到的关注有限。本综述将总结有关周细胞代谢的现有数据,并讨论信号通路与代谢途径偏好转变之间的耦合关系,这种耦合最终调节周细胞的静止、自我更新和分化。还将强调代谢过程失调与周细胞病变发展之间的关联。尽管关于周细胞分类及其分化功能能力仍存在争议,但周细胞正越来越多地被用作促进组织愈合和再生的细胞治疗工具。最终,治疗方法的疗效取决于有效控制/优化植入周细胞命运的能力。因此,我们将确定需要填补的知识空白,以便更有效地利用对周细胞进行治疗性操控的机会,来控制组织重塑中的病理结果。